title: Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
authors.affiliation: University Hospital Ghent, Ghent, Belgium. Marc.Peeters@uza.be
authors.forename: Marc
authors.initials: M
authors.lastname: Peeters
authors.forename: Timothy Jay
authors.initials: TJ
authors.lastname: Price
authors.forename: Andrés
authors.initials: A
authors.lastname: Cervantes
authors.forename: Alberto F
authors.initials: AF
authors.lastname: Sobrero
authors.forename: Michel
authors.initials: M
authors.lastname: Ducreux
authors.forename: Yevhen
authors.initials: Y
authors.lastname: Hotko
authors.forename: Thierry
authors.initials: T
authors.lastname: André
authors.forename: Emily
authors.initials: E
authors.lastname: Chan
authors.forename: Florian
authors.initials: F
authors.lastname: Lordick
authors.forename: Cornelis J A
authors.initials: CJ
authors.lastname: Punt
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Strickland
authors.forename: Gregory
authors.initials: G
authors.lastname: Wilson
authors.forename: Tudor-Eliade
authors.initials: TE
authors.lastname: Ciuleanu
authors.forename: Laslo
authors.initials: L
authors.lastname: Roman
authors.forename: Eric
authors.initials: E
authors.lastname: Van Cutsem
authors.forename: Valentina
authors.initials: V
authors.lastname: Tzekova
authors.forename: Simon
authors.initials: S
authors.lastname: Collins
authors.forename: Kelly S
authors.initials: KS
authors.lastname: Oliner
authors.forename: Alan
authors.initials: A
authors.lastname: Rong
authors.forename: Jennifer
authors.initials: J
authors.lastname: Gansert